Literature DB >> 10984520

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.

N Kim1, P R Odgren, D K Kim, S C Marks, Y Choi.   

Abstract

Tumor necrosis factor-related, activation-induced cytokine (TRANCE), a tumor necrosis factor family member, mediates survival of dendritic cells in the immune system and is required for osteoclast differentiation and activation in the skeleton. We report the skeletal phenotype of TRANCE-deficient mice and its rescue by the TRANCE transgene specifically expressed in lymphocytes. TRANCE-deficient mice showed severe osteopetrosis, with no osteoclasts, marrow spaces, or tooth eruption, and exhibited profound growth retardation at several skeletal sites, including the limbs, skull, and vertebrae. These mice had marked chondrodysplasia, with thick, irregular growth plates and a relative increase in hypertrophic chondrocytes. Transgenic overexpression of TRANCE in lymphocytes of TRANCE-deficient mice rescued osteoclast development in two locations in growing long bones: excavation of marrow cavities permitting hematopoiesis in the marrow spaces, and remodeling of osteopetrotic woven bone in the shafts of long bones into histologically normal lamellar bone. However, osteoclasts in these mice failed to appear at the chondroosseous junction and the metaphyseal periosteum of long bones, nor were they present in tooth eruption pathways. These defects resulted in sclerotic metaphyses with persistence of club-shaped long bones and unerupted teeth, and the growth plate defects were largely unimproved by the TRANCE transgene. Thus, TRANCE-mediated regulation of the skeleton is complex, and impacts chondrocyte differentiation and osteoclast formation in a manner that likely requires local delivery of TRANCE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984520      PMCID: PMC27122          DOI: 10.1073/pnas.200294797

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

2.  TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.

Authors:  B R Wong; J Rho; J Arron; E Robinson; J Orlinick; M Chao; S Kalachikov; E Cayani; F S Bartlett; W N Frankel; S Y Lee; Y Choi
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

Review 3.  Parathyroid hormone-related protein and Indian hedgehog control the pace of cartilage differentiation.

Authors:  H M Kronenberg; K Lee; B Lanske; G V Segre
Journal:  J Endocrinol       Date:  1997-09       Impact factor: 4.286

Review 4.  Bone cell biology: the regulation of development, structure, and function in the skeleton.

Authors:  S C Marks; S N Popoff
Journal:  Am J Anat       Date:  1988-09

5.  Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein.

Authors:  A Vortkamp; K Lee; B Lanske; G V Segre; H M Kronenberg; C J Tabin
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

6.  Histochemistry and biochemistry of tartrate-resistant acid phosphatase (TRAP) and tartrate-resistant acid adenosine triphosphatase (TrATPase) in bone, bone marrow and spleen: implications for osteoclast ontogeny.

Authors:  A Lindunger; C A MacKay; B Ek-Rylander; G Andersson; S C Marks
Journal:  Bone Miner       Date:  1990-08

7.  Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation.

Authors:  E C Weir; W M Philbrick; M Amling; L A Neff; R Baron; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 8.  The basic and applied biology of tooth eruption.

Authors:  S C Marks
Journal:  Connect Tissue Res       Date:  1995       Impact factor: 3.417

9.  Skeletal biology in the toothless (osteopetrotic) rat.

Authors:  M F Seifert; S N Popoff; S C Marks
Journal:  Am J Anat       Date:  1988-10

10.  Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice.

Authors:  K T Sundquist; M G Cecchini; S C Marks
Journal:  Bone       Date:  1995-01       Impact factor: 4.398

View more
  103 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

Review 3.  Paget disease of bone.

Authors:  G David Roodman; Jolene J Windle
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 4.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

5.  ATP6v0d2 deficiency increases bone mass, but does not influence ovariectomy-induced bone loss.

Authors:  Taesoo Kim; Hyunil Ha; Nacksung Kim; Eui-Soon Park; Jaerang Rho; Eun Cheol Kim; Joseph Lorenzo; Yongwon Choi; Seoung Hoon Lee
Journal:  Biochem Biophys Res Commun       Date:  2010-10-30       Impact factor: 3.575

6.  TRAF3 enforces the requirement for T cell cross-talk in thymic medullary epithelial development.

Authors:  S Rhiannon Jenkinson; Joy A Williams; Hyein Jeon; Jingjing Zhang; Takeshi Nitta; Izumi Ohigashi; Michael Kruhlak; Saulius Zuklys; Susan Sharrow; Anthony Adams; Larry Granger; Yongwon Choi; Ulrich Siebenlist; Gail A Bishop; Georg A Hollander; Yousuke Takahama; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

7.  RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.

Authors:  Christopher A Nelson; Julia T Warren; Michael W-H Wang; Steven L Teitelbaum; Daved H Fremont
Journal:  Structure       Date:  2012-10-02       Impact factor: 5.006

Review 8.  Altered bone remodeling in psoriatic arthritis.

Authors:  Kofi A Mensah; Edward M Schwarz; Christopher T Ritchlin
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

9.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 10.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.